Article Text
Abstract
Posterior reversible encephalopathy syndrome (PRES) may present with diverse clinical symptoms including visual disturbance, headache, seizures and impaired consciousness. MRI shows oedema, usually involving the posterior subcortical regions. Triggering factors include hypertension, pre-eclampsia/eclampsia, renal failure, cytotoxic agents and autoimmune conditions. The mechanism underlying PRES is not certain, but endothelial dysfunction is implicated. Treatment is supportive and involves correcting the underlying cause and managing associated complications, such as seizures. Although most patients recover, PRES is not always reversible and may be associated with considerable morbidity and even mortality.
- stroke
Statistics from Altmetric.com
Footnotes
Contributors JDT, AGK and TH undertook design of the article, drafting of the article and critical review of the article. MAK undertook drafting of the article and critical review of the article.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned. Externally peer reviewed by Aaron Berkowitz, Pasadena, California, USA.
Linked Articles
- Editors’ commentary
Read the full text or download the PDF:
Other content recommended for you
- The posterior reversible encephalopathy syndrome: what's certain, what's new?
- Reversible cerebral vasoconstriction syndrome
- Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications
- Thunderclap headache
- Cerebral-autoregulatory dysfunction syndrome
- Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
- Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion
- Postpartum headache: diagnostic considerations
- Postpartum vertebral artery dissection with posterior reversible encephalopathy syndrome
- Guillain-Barré syndrome and posterior reversible leukoencephalopathy syndrome: a rare association